OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether high-dose angiotensin II receptor blocker
(ARB) monotherapy or combination therapy with ARB and calcium channel blockers is more
effective in reducing the incidence of cardiovascular events in Japanese elderly high-risk
hypertensive patients not adequately controlled by standard dose ARB alone.
Phase:
Phase 4
Details
Lead Sponsor:
OSCAR Study
Collaborator:
Japan Heart Foundation
Treatments:
Amlodipine Angiotensin II Type 1 Receptor Blockers Calcium Calcium Channel Blockers Calcium, Dietary Olmesartan Olmesartan Medoxomil